Please Share this link to POI’s Free Newsletter
Join POI’s Search Engine Registration Now Free. Please Share Link
Great Newsin Israel on The Medical Front
Once-a-day injection to treat Parkinson’s. Israel’s Pharma Two B (see here previously) is presenting the full results of its Phase 3 trial of its once-a-day injection of its P2B001 treatment for Parkinson’s disease. P2B001 combines low-dose pramipexole with low-dose rasagiline. It relieves PD symptoms with few side effects.
Sheba implements fast cancer diagnosis. Sheba Medical Center has deployed a new accelerated, AI-powered cancer diagnostics research platform to improve patient diagnosis, treatment, and outcomes. It utilizes solutions of various Israeli startups, including that of Imagene (see here previously).
Shalom Rafael Haar Founder
Comments